Respiratory Syncytial Virus: Old Challenges and New Approaches-Reference-Cited by-同舟云学术

Respiratory Syncytial Virus: Old Challenges and New Approaches

Published:2005-01 Issue:1 Volume:34 Page:62-68
ISSN:0090-4481
Container-title:Pediatric Annals
language:en
Short-container-title:Pediatr Ann

Author:

Chávez-Bueno Susana,Mejías Asunción,Jafri Hasan S,Ramilo Octavio

Publisher

SLACK, Inc.

Subject

Pediatrics, Perinatology, and Child Health

Reference35 articles.

1. 1. Leader S Kohlhase K. Recent trends severe respiratory syncytial virus among US infants 1997 to 2000. J 2003;143(5 Suppl):S127-132.

2. 2. Sigurs N Gustafsson PM Bjarnason R et Severe respiratory syncytial virus tis in infancy and asthma and allergy at 13. Am J Respir Crit Care Med. 2004 ahead of print].

3. 3. Stein RT Sherrill D Morgan WJ et al. piratory syncytial virus in early life and of wheeze and allergy by age 13 Lancet. 1999 354(9178):541-545.

4. 4. Shay DK Holraan RC Newman RD et Bronchiolitis-associated among US children 1980-1996. JAMA. 282(15): 1440-1446.

5. 5. Iwane MK Edwards KM Szilagyi PG et Population-based surveillance for tions associated with respiratory virus influenza virus and viruses among young children. 2004; 13(6): 758- 1 764.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Syncytial Virus is the Most Common Causative Agent of Viral Bronchiolitis in Young Children: An Updated Review;Current Pediatric Reviews;2023-05

2. Major Histocompatibility Complex-Dependent Cytotoxic T Lymphocyte Repertoire and Functional Avidity Contribute to Strain-Specific Disease Susceptibility after Murine Respiratory Syncytial Virus Infection;Journal of Virology;2011-07-27

3. Local cytokine response upon respiratory syncytial virus infection;Immunology Letters;2011-05

4. Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice;Journal of Virology;2010-01-15

5. Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria;Clinical Therapeutics;2008-04